Clinical Trial: Smart MDI Study (CIP343)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Diabetes Mellitus, Type 1
Study Type: INTERVENTIONAL
Official Title: Smart MDI Randomized Controlled Trial in Subjects With Type 1 Diabetes (Smart MDI Study)
Brief Summary:
The purpose of the study is to evaluate the effectiveness of the Smart MDI system with InPen™ and Simplera™ in comparison with Multiple Daily Injection (MDI) therapy with intermittent scanning or real-time Continuous Glucose Monitoring (isCGM/CGM) over 6 months duration in people with type 1 diabetes to support the market access and therapy adoption of the Smart MDI system.
Read more